Register entry
- Registered sites
- 2
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 2
- Base
- Italy
Authorisation
Registered operations
Finished drug manufacture1Packaging1
Sites
Registered establishments
2| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| CIT SRL | VIA PRIMO VILLA 17, BURAGO DI MOLGORA, 20875, Italy (ITA) | Packaging | 1000190495432126969 |
| Cit Co., Ltd. | 110 Hapdeoksandan 1-ro, Hapdeok-eup, Dangjin, Chungnam 31810, Korea, South (KOR) | Finished drug manufacture | 3008160676690081646 |
Compare
Comparable companies in Italy
- Novo Nordisk Production Belgium SA2 sites · 24 NDC
- Indena SpA2 sites · 15 NDC
- Italfarmaco S.A.2 sites · 15 NDC
- Doppel Farmaceutici S.r.l.2 sites · 10 NDC
- ALFASIGMA SPA2 sites · 1 NDC
- Bioindustria Laboratorio Italiano Medicinali S.p.A.2 sites · 0 NDC
- FIS FABBRICA ITALIANA SINTETICI SPA3 sites · 128 NDC
- GUNA-Spa1 site · 83 NDC
- BSP Pharmaceuticals SpA1 site · 40 NDC
- Kedrion Biopharma Inc.3 sites · 28 NDC
Enquiry
Common questions
- Is Cit Co., Ltd. FDA approved?
- Cit Co., Ltd. holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Cit Co., Ltd.'s drugs manufactured?
- At registered sites in Italy, South Korea. The FDA register lists BURAGO DI MOLGORA; Chungnam 31810. Registered operations: finished drug manufacture, packaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.